» Articles » PMID: 29520590

Role of Urinary Tract Infection in Bladder Cancer: a Systematic Review and Meta-analysis

Overview
Journal World J Urol
Specialty Urology
Date 2018 Mar 10
PMID 29520590
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We sought to examine the literature reporting the effect of urinary tract infection (UTI) on non-schistosomiasis-related UBC (UBC) through a systematic review and meta-analysis.

Methods: A predefined study protocol was developed according to PRISMA. Medline and Scopus were searched for all studies investigating exposure to UTI with UBCNS as the primary outcome. Potential studies were screened against eligibility criteria. Clinical heterogeneity was assessed and groups with more than two studies were evaluated by random effect meta-analysis. Study-level bias was assessed with the Newcastle-Ottawa Scale (NOS). In cases of substantial between study heterogeneity (I > 50%), predefined sensitivity and subgroup analyses were performed.

Results: Of 16 eligible studies, eight case-control studies spanning four decades and five countries were suitable for quantitative analysis. Main analysis favored exposure to UTI increasing risk of subsequent UBC (RR 1.33 [95% CI 1.14-1.55]). This effect was no longer statistically significant after excluding studies published prior to year 2000 and at high risk of bias. Between study heterogeneity was considerable for nearly all analyses and not reduced by predefined sensitivity or subgroup analyses.

Conclusion: Exposure to UTI favors increased risk for UBC, particularly in men, but these effects were statistically insignificant when pooling data from the most recent and highest quality studies. These data do not support findings of previously published studies, that report on heterogenous populations with poor definitions of UTI and minimal control for important confounders. Results from previous studies should be viewed as hypothesis generating. This review highlights the need for higher quality investigation.

Citing Articles

Emerging drivers of female bladder cancer: a pathway to precision prevention and treatment.

Zhang J, Jia H, Han H Front Oncol. 2025; 15:1497637.

PMID: 40027137 PMC: 11867944. DOI: 10.3389/fonc.2025.1497637.


Successful Treatment of Non-invasive Bladder Cancer During Pregnancy: Diagnostic and Management Challenges.

Reddy Depa A, Reddy Beeravalli R, Bommiti A, Pawar S Cureus. 2025; 16(12):e75417.

PMID: 39791033 PMC: 11711065. DOI: 10.7759/cureus.75417.


Molecular Basis of Tumorigenesis of Bladder Cancer and Emerging Concepts in Developing Therapeutic Targets.

Abdeltwab R, Yacoub E, Rashad A, Shohdy K Bladder Cancer. 2024; 9(4):313-322.

PMID: 38994247 PMC: 11165923. DOI: 10.3233/BLC-230025.


The role of microbiota in tumorigenesis, progression and treatment of bladder cancer.

Peng Z, Zhuang J, Shen B Microbiome Res Rep. 2024; 3(1):5.

PMID: 38455086 PMC: 10917617. DOI: 10.20517/mrr.2023.47.


Risk of Urological Cancer Among Boys and Men Born with Hypospadias: A Swedish Population-based Study.

Phillips L, Lundholm C, Almqvist C, Nordenvall A, Nordenskjold A Eur Urol Open Sci. 2023; 57:51-59.

PMID: 38020521 PMC: 10658418. DOI: 10.1016/j.euros.2023.09.009.


References
1.
Howe G, Burch J, Miller A, Cook G, Esteve J, Morrison B . Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst. 1980; 64(4):701-13. View

2.
Sullivan J . Epidemiologic survey of bladder cancer in greater New Orleans. J Urol. 1982; 128(2):281-3. DOI: 10.1016/s0022-5347(17)52886-4. View

3.
La Vecchia C, Negri E, DAvanzo B, Savoldelli R, Franceschi S . Genital and urinary tract diseases and bladder cancer. Cancer Res. 1991; 51(2):629-31. View

4.
Sterne J, Sutton A, Ioannidis J, Terrin N, Jones D, Lau J . Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343:d4002. DOI: 10.1136/bmj.d4002. View

5.
Sun L, Lin C, Liang J, Liu S, Sung F, Chang Y . Urinary tract infection increases subsequent urinary tract cancer risk: a population-based cohort study. Cancer Sci. 2013; 104(5):619-23. PMC: 7657239. DOI: 10.1111/cas.12127. View